查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405899

臨床試驗物流市場規模、佔有率、趨勢分析報告：按服務、按階段、按治療領域、按最終用途、按地區、細分市場預測，2024-2030 年

Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗供應物流市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球臨床試驗供應物流市場規模將達到62.5億美元，2024年至2030年複合年成長率為7.6%。

這是由於臨床物流市場先進技術和創新的興起、嚴格法規的實施以及由於COVID-19大流行等疾病流行率上升而對臨床試驗的需求不斷增加所推動的。

最初，由於供應鏈中斷以及政府為防止病毒傳播而削減商業航空公司的開支，COVID-19 大流行對市場產生了負面影響。然而，由於對預防這種疾病的 COVID-19 疫苗的需求不斷增加，市場很快就恢復並開始顯著成長。例如，根據世界衛生組織的數據，截至2022年8月2日，有169種疫苗處於臨床開發階段，198種疫苗處於臨床前階段。

臨床試驗用品提供者對供應鏈管理軟體的投資是巨大的。臨床試驗的複雜性日益增加和市場競爭的加劇正在推動供應鏈管理中新技術的採用。隨著行業公司擴大採用新技術，對庫存管理、供應鏈規劃和補充供應鏈管理軟體的需求預計將會增加。

臨床試驗供應物流市場報告亮點

  • 在服務業中，物流配送將在2023年佔據市場佔有率，達到25.33%。這是由於 COVID-19 爆發導致臨床試驗增加。
  • 以階段來看，2023年第三期銷售佔有率最大。
  • 依治療領域分類，心血管疾病在預測期內複合年成長率最快，達 8.0%。這是由於市場參與企業為為市場帶來新穎性和創新而進行的投資數量增加。
  • 預計亞太地區在預測期內將實現 8.1% 的最快成長率。這是由於較低的招募成本、大量且多樣化的患者群以及對臨床試驗的有利政策。

目錄

第1章調查方法和範圍

第2章臨床試驗供應物流市場：執行摘要

  • 市場概述
  • 服務和階段簡介
  • 治療區域和最終用途的簡介
  • 競爭形勢概覽

第 3 章：臨床試驗供應物流市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 供應鏈的技術進步
    • 醫藥及生技製藥廠商研發投入增加
    • 擴大臨床實驗設施
  • 市場抑制因素分析
    • 物流方面的嚴格規定。
    • 藥品假冒
  • 臨床試驗供應物流市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析

第 4 章 臨床試驗供應物流：服務評估與趨勢分析

  • 2023年及2030年服務市場佔有率
  • 細分儀表板
  • 全球臨床試驗供應物流市場按服務展望
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 物流/配送
    • 儲存/保留
    • 包裝、標籤、蒙眼
    • 製造業
    • 比較器採購
    • 其他

第 5 章 臨床試驗供應物流：階段估計與趨勢分析

  • 2023年及2030年階段市場佔有率
  • 細分儀表板
  • 全球臨床試驗供應物流市場分階段展望
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段

第6章 臨床試驗供應物流：治療領域的估計與趨勢分析

  • 2023 年和 2030 年治療領域市場佔有率
  • 細分儀表板
  • 按治療領域分類的全球臨床試驗供應物流市場展望
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 腫瘤學
    • 中樞神經系統 (CNS) 疾病
    • 心血管疾病
    • 呼吸系統疾病
    • 其他

第 7 章 臨床試驗供應物流：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途區域分類的全球臨床試驗供應物流市場展望
  • 2018-2030 年市場規模、預測與趨勢分析如下
    • 藥品
    • 生物製藥
    • 醫療設備

第8章區域業務分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030 年標記大小和預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 中東和非洲臨床試驗供應物流市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
  • 供應商形勢
    • List Of Key Distributors And Channel Partners
    • Key Customers
    • Key Company Market Share Analysis, 2023
    • Thermo Fisher Scientific（Patheon）
    • Catalent, Inc.
    • Parexel International（MA）Corporation
    • Almac Group
    • Marken
    • Piramal Pharma Solutions
    • UDG HEALTHCARE
    • DHL
    • FedEx
    • Movianto
    • Packaging Coordinators Inc
Product Code: GVR-4-68038-356-0

Clinical Trials Supply & Logistics Market Growth & Trends:

The global clinical trials supply & logistics market size is expected to reach USD 6.25 billion by 2030, registering a CAGR of 7.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.

Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.

There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.

Clinical Trials Supply & Logistics Market Report Highlights:

  • In service segment, logistics & distribution dominated the market in 2023 with a share of 25.33%. This is due to the rise in clinical trials due to COVID- 19 pandemic
  • Based on phase, The phase III segment accounted for the largest revenue share in 2023
  • Based on therapeutic area, cardiovascular diseases accounted for the fastest CAGR of 8.0% during the forecast period. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market
  • Asia Pacific is anticipated to register the fastest growth rate of 8.1% during the forecast period. This is due to low recruitment cost, region has access to a large and diversified patient pool, and favorable policies that make the region desirable for clinical trials

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation And Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Service Segment
      • 1.1.1.2. Phase Segment
      • 1.1.1.3. Therapeutics Area Segment
      • 1.1.1.4. End use segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List Of Primary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Clinical Trial Supply & Logistics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Services And Phase Snapshots
  • 2.3. Therapeutic Area And End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Clinical Trial Supply & Logistics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Technological advancements in supply chain
    • 3.4.2. Increasing R&D investment by pharmaceutical and biopharmaceutical firms
    • 3.4.3. Expansion of clinical trial sites
  • 3.5. Market Restraint Analysis
    • 3.5.1. Stringent regulation pertaining to logistics.
    • 3.5.2. Counterfeiting of drugs
  • 3.6. Clinical Trial Supply & Logistics Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat Of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Technological Landscape
      • 3.6.2.3. Economic Landscape

Chapter 4. Clinical Trial Supply & Logistics: Service Estimates & Trend Analysis

  • 4.1. Service Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Trial Supply & Logistics Market By Service Outlook
  • 4.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 4.4.1. Logistics & Distribution
      • 4.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.2. Storage & Retention
      • 4.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.3. Packaging, Labeling, And Blinding
      • 4.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.4. Manufacturing
      • 4.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.5. Comparator Sourcing
      • 4.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.4.6. Other
      • 4.4.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 5. Clinical Trial Supply & Logistics: Phase Estimates & Trend Analysis

  • 5.1. Phase Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Trial Supply & Logistics Market By Phase Outlook
  • 5.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 5.4.1. Phase I
      • 5.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.4.2. Phase II
      • 5.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.4.3. Phase III
      • 5.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.4.4. Phase IV
      • 5.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 6. Clinical Trial Supply & Logistics: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Therapeutic Area Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Trial Supply & Logistics Market By Therapeutic Area Outlook
  • 6.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 6.4.1. Oncology
      • 6.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.2. Central Nervous System (CNS) Disorders
      • 6.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.3. Cardiovascular Diseases
      • 6.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.4. Respiratory Diseases
      • 6.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 7. Clinical Trial Supply & Logistics: End Use Estimates & Trend Analysis

  • 7.1. End use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Clinical Trial Supply & Logistics Market By End use Area Outlook
  • 7.4. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 7.4.1. Pharmaceutical
      • 7.4.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.4.2. Biologicals
      • 7.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.4.3. Medical Devices
      • 7.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Competitive Scenario
      • 8.5.1.3. Regulatory Framework
      • 8.5.1.4. U.S. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Competitive Scenario
      • 8.6.1.3. Regulatory Framework
      • 8.6.1.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.3. Spain
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.4. France
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.5. Italy
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.6. Denmark
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.8. Norway
      • 8.6.8.1. Key Country Dynamics
      • 8.6.8.2. Competitive Scenario
      • 8.6.8.3. Regulatory Framework
      • 8.6.8.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. JAPAN
      • 8.7.1.1. Key Country Dynamics
      • 8.7.1.2. Competitive Scenario
      • 8.7.1.3. Regulatory Framework
      • 8.7.1.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.4. South Korea
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.5. Thailand
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.6. Australia
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key Country Dynamics
      • 8.8.1.2. Competitive Scenario
      • 8.8.1.3. Regulatory Framework
      • 8.8.1.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Mexico Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. MEA Clinical Trial Supply & Logistics Market, 2018 - 2030 (USD Million)
    • 8.9.2. South Africa
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Competitive Scenario
      • 8.9.2.3. Regulatory Framework
      • 8.9.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Competitive Scenario
      • 8.9.3.3. Regulatory Framework
      • 8.9.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Competitive Scenario
      • 8.9.4.3. Regulatory Framework
      • 8.9.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.9.5. Kuwait
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Competitive Scenario
      • 8.9.5.3. Regulatory Framework
      • 8.9.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company /Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List Of Key Distributors And Channel Partners
    • 9.3.2. Key Customers
    • 9.3.3. Key Company Market Share Analysis, 2023
    • 9.3.4. Thermo Fisher Scientific (Patheon)
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Catalent, Inc.
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Parexel International (MA) Corporation
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Almac Group
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Marken
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Piramal Pharma Solutions
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. UDG HEALTHCARE
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. DHL
      • 9.3.11.1. Overview
      • 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.11.3. Product Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. FedEx
      • 9.3.12.1. Overview
      • 9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.12.3. Product Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Movianto
      • 9.3.13.1. Overview
      • 9.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.13.3. Product Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. Packaging Coordinators Inc
      • 9.3.14.1. Overview
      • 9.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.14.3. Product Benchmarking
      • 9.3.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 4 North America Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 5 North America Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 6 North America Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 U.S. Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 8 U.S. Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 9 U.S. Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 10 U.S. Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11 Canada Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 12 Canada Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 13 Canada Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 17 Europe Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 18 Europe Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 19 Europe Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 UK Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 21 UK Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 22 UK Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 23 UK Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 25 Germany Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 26 Germany Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 27 Germany Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 France Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 29 France Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 30 France Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 31 France Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 33 Italy Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 34 Italy Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 35 Italy Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 37 Spain Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 38 Spain Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 39 Spain Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Sweden Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 41 Sweden Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 42 Sweden Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 43 Sweden Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 45 Norway Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 46 Norway Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 47 Norway Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Denmark Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 49 Denmark Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 50 Denmark Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 51 Denmark Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 Japan Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 58 Japan Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 59 Japan Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 60 Japan Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 China Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 62 China Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 63 China Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 64 China Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 India Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 66 India Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 67 India Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 68 India Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 Australia Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 70 Australia Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 71 Australia Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 72 Australia Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 South Korea Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 74 South Korea Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 75 South Korea Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 76 South Korea Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 77 Thailand Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 78 Thailand Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 79 Thailand Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 80 Thailand Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Latin America Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 82 Latin America Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 83 Latin America Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 84 Latin America Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 85 Latin America Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 86 Brazil Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 87 Brazil Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 88 Brazil Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 89 Brazil Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 90 Mexico Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 91 Mexico Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 92 Mexico Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 93 Mexico Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Argentina Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 95 Argentina Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 96 Argentina Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 97 Argentina Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 98 MEA Clinical Trial Supply & Logistics Market, Region, 2018 - 2030 (USD Million)
  • Table 99 MEA Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 100 MEA Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 101 MEA Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 102 MEA Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 103 South Africa Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 104 South Africa Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 105 South Africa Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 South Africa Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 111 UAE Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 112 UAE Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 113 UAE Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 114 UAE Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait Clinical Trial Supply & Logistics Market, By Service, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Clinical Trial Supply & Logistics Market, By Phase, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Clinical Trial Supply & Logistics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews In North America
  • Fig. 5 Primary Interviews In Europe
  • Fig. 6 Primary Interviews In APAC
  • Fig. 7 Primary Interviews In Latin America
  • Fig. 8 Primary Interviews In MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling For Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Clinical Trial Supply & Logistics Market: Market Outlook
  • Fig. 14 Clinical Trial Supply & Logistics Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Clinical Trial Supply & Logistics Market Driver Impact
  • Fig. 20 Clinical Trial Supply & Logistics Market Restraint Impact
  • Fig. 21 Clinical Trial Supply & Logistics Market Strategic Initiatives Analysis
  • Fig. 22 Clinical Trial Supply & Logistics Market: Service Movement Analysis
  • Fig. 23 Clinical Trial Supply & Logistics Market: Service Outlook And Key Takeaways
  • Fig. 24 Logistics & distribution Market Estimates And Forecast, 2018 - 2030
  • Fig. 25 Storage & retention Market Estimates And Forecast, 2018 - 2030
  • Fig. 26 Packaging, labeling, and blinding Market Estimates And Forecast, 2018 - 2030
  • Fig. 27 Manufacturing Market Estimates And Forecast, 2018 - 2030
  • Fig. 28 Comparator sourcing Market Estimates And Forecast, 2018 - 2030
  • Fig. 29 Other Market Estimates And Forecast, 2018 - 2030
  • Fig. 30 Clinical Trial Supply & Logistics Market: Phase Movement Analysis
  • Fig. 31 Clinical Trial Supply & Logistics Market: Phase Outlook And Key Takeaways
  • Fig. 32 Phase I Market Estimates And Forecasts, 2018 - 2030
  • Fig. 33 Phase II Market Estimates And Forecasts, 2018 - 2030
  • Fig. 34 Phase III Market Estimates And Forecasts, 2018 - 2030
  • Fig. 35 Phase IV Market Estimates And Forecasts, 2018 - 2030
  • Fig. 36 Clinical Trial Supply & Logistics Market: Therapeutic Area Movement Analysis
  • Fig. 37 Clinical Trial Supply & Logistics Market: Therapeutic Area Outlook And Key Takeaways
  • Fig. 38 Oncology Market Estimates And Forecasts, 2018 - 2030
  • Fig. 39 Cardiovascular Market Estimates And Forecasts, 2018 - 2030
  • Fig. 40 Respiratory disease Market Estimates And Forecasts, 2018 - 2030
  • Fig. 41 CNS & Mental Disorders Market Estimates And Forecasts, 2018 - 2030
  • Fig. 42 Others Market Estimates And Forecasts, 2018 - 2030
  • Fig. 43 Clinical Trial Supply & Logistics Market: End Use Movement Analysis
  • Fig. 44 Clinical Trial Supply & Logistics Market: End Use Outlook And Key Takeaways
  • Fig. 45 Pharmaceuticals Market Estimates And Forecasts, 2018 - 2030
  • Fig. 46 Biologicals Market Estimates And Forecasts, 2018 - 2030
  • Fig. 47 Medical Device Market Estimates And Forecasts, 2018 - 2030
  • Fig. 48 Global Clinical Trial Supply & Logistics Market: Regional Movement Analysis
  • Fig. 49 Global Clinical Trial Supply & Logistics Market: Regional Outlook And Key Takeaways
  • Fig. 50 Global Clinical Trial Supply & Logistics Market Share And Leading Players
  • Fig. 51 North America Market Share And Leading Players
  • Fig. 52 Europe Market Share And Leading Players
  • Fig. 53 Asia Pacific Market Share And Leading Players
  • Fig. 54 Latin America Market Share And Leading Players
  • Fig. 55 Middle East & Africa Market Share And Leading Players
  • Fig. 56 North America: SWOT
  • Fig. 57 Europe SWOT
  • Fig. 58 Asia Pacific SWOT
  • Fig. 59 Latin America SWOT
  • Fig. 60 MEA SWOT
  • Fig. 61 North America, By Country
  • Fig. 62 North America
  • Fig. 63 North America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 64 U.S.
  • Fig. 65 U.S. Market Estimates And Forecasts, 2018 - 2030
  • Fig. 66 Canada
  • Fig. 67 Canada Market Estimates And Forecasts, 2018 - 2030
  • Fig. 68 Europe
  • Fig. 69 Europe Market Estimates And Forecasts, 2018 - 2030
  • Fig. 70 UK
  • Fig. 71 UK Market Estimates And Forecasts, 2018 - 2030
  • Fig. 72 Germany
  • Fig. 73 Germany Market Estimates And Forecasts, 2018 - 2030
  • Fig. 74 France
  • Fig. 75 France Market Estimates And Forecasts, 2018 - 2030
  • Fig. 76 Italy
  • Fig. 77 Italy Market Estimates And Forecasts, 2018 - 2030
  • Fig. 78 Spain
  • Fig. 79 Spain Market Estimates And Forecasts, 2018 - 2030
  • Fig. 80 Denmark
  • Fig. 81 Denmark Market Estimates And Forecasts, 2018 - 2030
  • Fig. 82 Sweden
  • Fig. 83 Sweden Market Estimates And Forecasts, 2018 - 2030
  • Fig. 84 Norway
  • Fig. 85 Norway Market Estimates And Forecasts, 2018 - 2030
  • Fig. 86 Asia Pacific
  • Fig. 87 Asia Pacific Market Estimates And Forecasts, 2018 - 2030
  • Fig. 88 China
  • Fig. 89 China Market Estimates And Forecasts, 2018 - 2030
  • Fig. 90 Japan
  • Fig. 91 Japan Market Estimates And Forecasts, 2018 - 2030
  • Fig. 92 India
  • Fig. 93 India Market Estimates And Forecasts, 2018 - 2030
  • Fig. 94 Thailand
  • Fig. 95 Thailand Market Estimates And Forecasts, 2018 - 2030
  • Fig. 96 South Korea
  • Fig. 97 South Korea Market Estimates And Forecasts, 2018 - 2030
  • Fig. 98 Australia
  • Fig. 99 Australia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 100 Latin America
  • Fig. 101 Latin America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 102 Brazil
  • Fig. 103 Brazil Market Estimates And Forecasts, 2018 - 2030
  • Fig. 104 Mexico
  • Fig. 105 Mexico Market Estimates And Forecasts, 2018 - 2030
  • Fig. 106 Argentina
  • Fig. 107 Argentina Market Estimates And Forecasts, 2018 - 2030
  • Fig. 108 Middle East And Africa
  • Fig. 109 Middle East And Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 110 South Africa
  • Fig. 111 South Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 112 Saudi Arabia
  • Fig. 113 Saudi Arabia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 114 UAE
  • Fig. 115 UAE Market Estimates And Forecasts, 2018 - 2030
  • Fig. 116 Kuwait
  • Fig. 117 Kuwait Market Estimates And Forecasts, 2018 - 2030
  • Fig. 118 Market Share Of Key Market Players - Clinical Trial Supply & Logistics Market